| species |
title |
pathway |
Anopheles gambiae |
Cytoplasmic ribosomal proteins |
https://identifiers.org/wikipathways/WP1239_r117043 |
Anopheles gambiae |
Eukaryotic transcription initiation |
https://identifiers.org/wikipathways/WP1238_r117221 |
Anopheles gambiae |
Heme biosynthesis |
https://identifiers.org/wikipathways/WP1221_r117222 |
Anopheles gambiae |
Lipid remodeling |
https://identifiers.org/wikipathways/WP5290_r124969 |
Anopheles gambiae |
Pentose phosphate pathway |
https://identifiers.org/wikipathways/WP1231_r118327 |
Anopheles gambiae |
TCA cycle |
https://identifiers.org/wikipathways/WP1227_r117225 |
Anopheles gambiae |
mRNA processing |
https://identifiers.org/wikipathways/WP1229_r122784 |
Arabidopsis thaliana |
Cytokinin signaling |
https://identifiers.org/wikipathways/WP2944_r118618 |
Arabidopsis thaliana |
Flavonoid biosynthesis |
https://identifiers.org/wikipathways/WP1538_r126393 |
Arabidopsis thaliana |
Glycolysis |
https://identifiers.org/wikipathways/WP2621_r125286 |
Arabidopsis thaliana |
Linoleate biosynthesis |
https://identifiers.org/wikipathways/WP1996_r117243 |
Arabidopsis thaliana |
Seed development |
https://identifiers.org/wikipathways/WP2279_r125284 |
Arabidopsis thaliana |
Sucrose metabolism |
https://identifiers.org/wikipathways/WP2623_r118414 |
Arabidopsis thaliana |
TCA cycle (Krebs cycle) |
https://identifiers.org/wikipathways/WP2624_r123106 |
Arabidopsis thaliana |
UDP-L-arabinose biosynthesis I from UDP-xylose |
https://identifiers.org/wikipathways/WP3015_r118606 |
Bacillus subtilis |
Folate biosynthesis |
https://identifiers.org/wikipathways/WP2360_r118112 |
Bacillus subtilis |
Response regulator aspartate phosphatase interactions |
https://identifiers.org/wikipathways/WP1466_r126353 |
Bos taurus |
AGE/RAGE pathway |
https://identifiers.org/wikipathways/WP3124_r89797 |
Bos taurus |
AMPK signaling |
https://identifiers.org/wikipathways/WP3154_r117473 |
Bos taurus |
ATM signaling pathway |
https://identifiers.org/wikipathways/WP3221_r117478 |
Bos taurus |
Actin cytoskeleton regulation |
https://identifiers.org/wikipathways/WP1062_r120933 |
Bos taurus |
Amino acid conjugation of benzoic acid |
https://identifiers.org/wikipathways/WP1008_r105985 |
Bos taurus |
Angiogenesis |
https://identifiers.org/wikipathways/WP3184_r128739 |
Bos taurus |
Apoptosis |
https://identifiers.org/wikipathways/WP1018_r95783 |
Bos taurus |
Arrhythmogenic right ventricular cardiomyopathy |
https://identifiers.org/wikipathways/WP3195_r117476 |
Bos taurus |
Aryl hydrocarbon receptor |
https://identifiers.org/wikipathways/WP3226_r117477 |
Bos taurus |
Arylamine metabolism |
https://identifiers.org/wikipathways/WP993_r105949 |
Bos taurus |
BDNF signaling pathway |
https://identifiers.org/wikipathways/WP3141_r105936 |
Bos taurus |
Biogenic amine synthesis |
https://identifiers.org/wikipathways/WP3168_r117480 |
Bos taurus |
Cell cycle |
https://identifiers.org/wikipathways/WP1083_r120485 |
Bos taurus |
Cell differentiation - index |
https://identifiers.org/wikipathways/WP3202_r123272 |
Bos taurus |
Cholesterol biosynthesis |
https://identifiers.org/wikipathways/WP1070_r118367 |
Bos taurus |
Complement and coagulation cascades |
https://identifiers.org/wikipathways/WP1056_r117491 |
Bos taurus |
Cori cycle |
https://identifiers.org/wikipathways/WP3114_r123384 |
Bos taurus |
Corticotropin-releasing hormone |
https://identifiers.org/wikipathways/WP3265_r108255 |
Bos taurus |
Cytoplasmic ribosomal proteins |
https://identifiers.org/wikipathways/WP1071_r117041 |
Bos taurus |
DNA replication |
https://identifiers.org/wikipathways/WP983_r117497 |
Bos taurus |
Dopamine metabolism |
https://identifiers.org/wikipathways/WP3155_r107062 |
Bos taurus |
Dopaminergic neurogenesis |
https://identifiers.org/wikipathways/WP3196_r117498 |
Bos taurus |
Drug induction of bile acid pathway |
https://identifiers.org/wikipathways/WP3253_r128628 |
Bos taurus |
Ectoderm differentiation |
https://identifiers.org/wikipathways/WP3208_r117500 |
Bos taurus |
Electron transport chain |
https://identifiers.org/wikipathways/WP1002_r117502 |
Bos taurus |
Endoderm differentiation |
https://identifiers.org/wikipathways/WP3240_r117507 |
Bos taurus |
Endothelin pathways |
https://identifiers.org/wikipathways/WP3246_r117509 |
Bos taurus |
Exercise-induced circadian regulation |
https://identifiers.org/wikipathways/WP3230_r117510 |
Bos taurus |
Fatty acid biosynthesis |
https://identifiers.org/wikipathways/WP1020_r125343 |
Bos taurus |
Fatty acid omega-oxidation |
https://identifiers.org/wikipathways/WP970_r117512 |
Bos taurus |
Folate metabolism |
https://identifiers.org/wikipathways/WP1075_r120905 |
Bos taurus |
Folate-alcohol and cancer pathway |
https://identifiers.org/wikipathways/WP3120_r117516 |
Bos taurus |
Glial cell differentiation |
https://identifiers.org/wikipathways/WP3203_r117053 |
Bos taurus |
Globo sphingolipid metabolism |
https://identifiers.org/wikipathways/WP3278_r117522 |
Bos taurus |
Glutathione metabolism |
https://identifiers.org/wikipathways/WP3207_r107067 |
Bos taurus |
Glycine metabolism |
https://identifiers.org/wikipathways/WP3142_r117523 |
Bos taurus |
Glycolysis and gluconeogenesis |
https://identifiers.org/wikipathways/WP1027_r117532 |
Bos taurus |
Hematopoietic stem cell differentiation |
https://identifiers.org/wikipathways/WP3174_r117536 |
Bos taurus |
Hepatocyte growth factor receptor signaling |
https://identifiers.org/wikipathways/WP1046_r118734 |
Bos taurus |
Histone modifications |
https://identifiers.org/wikipathways/WP3123_r117544 |
Bos taurus |
Homologous recombination |
https://identifiers.org/wikipathways/WP1036_r118344 |
Bos taurus |
Hydrochloric acid secretion in parietal cells |
https://identifiers.org/wikipathways/WP3204_r117598 |
Bos taurus |
IL-17 signaling pathway |
https://identifiers.org/wikipathways/WP3176_r117959 |
Bos taurus |
Inflammatory response pathway |
https://identifiers.org/wikipathways/WP1040_r117545 |
Bos taurus |
Influenza A virus infection |
https://identifiers.org/wikipathways/WP3214_r105960 |
Bos taurus |
Integrated cancer pathway |
https://identifiers.org/wikipathways/WP3244_r117557 |
Bos taurus |
Interferon type I signaling pathways |
https://identifiers.org/wikipathways/WP3213_r107069 |
Bos taurus |
Interleukin-11 signaling pathway |
https://identifiers.org/wikipathways/WP3159_r117556 |
Bos taurus |
Irinotecan pathway |
https://identifiers.org/wikipathways/WP1080_r128653 |
Bos taurus |
Lidocaine metabolism |
https://identifiers.org/wikipathways/WP3254_r106002 |
Bos taurus |
Mesodermal commitment pathway |
https://identifiers.org/wikipathways/WP3183_r117550 |
Bos taurus |
Metapathway biotransformation |
https://identifiers.org/wikipathways/WP1006_r80841 |
Bos taurus |
Metastatic brain tumor |
https://identifiers.org/wikipathways/WP3259_r89837 |
Bos taurus |
Microtubule cytoskeleton regulation |
https://identifiers.org/wikipathways/WP3177_r117596 |
Bos taurus |
Mitochondrial long chain fatty acid beta-oxidation |
https://identifiers.org/wikipathways/WP989_r124928 |
Bos taurus |
Monoamine GPCRs |
https://identifiers.org/wikipathways/WP1076_r115322 |
Bos taurus |
Monoamine transport |
https://identifiers.org/wikipathways/WP3118_r117553 |
Bos taurus |
NAD biosynthesis II from tryptophan |
https://identifiers.org/wikipathways/WP3228_r117560 |
Bos taurus |
Neurotransmitter clearance in synaptic cleft |
https://identifiers.org/wikipathways/WP3165_r117564 |
Bos taurus |
Nicotine activity on chromaffin cells |
https://identifiers.org/wikipathways/WP3255_r117565 |
Bos taurus |
Nicotine metabolism |
https://identifiers.org/wikipathways/WP3185_r117574 |
Bos taurus |
Non-homologous end joining |
https://identifiers.org/wikipathways/WP979_r80791 |
Bos taurus |
Nuclear receptors in lipid metabolism and toxicity |
https://identifiers.org/wikipathways/WP981_r117571 |
Bos taurus |
Nucleotide GPCRs |
https://identifiers.org/wikipathways/WP1042_r120930 |
Bos taurus |
Nucleotide metabolism |
https://identifiers.org/wikipathways/WP3211_r117575 |
Bos taurus |
Oncostatin M signaling pathway |
https://identifiers.org/wikipathways/WP3277_r117572 |
Bos taurus |
Osteoblast signaling |
https://identifiers.org/wikipathways/WP1074_r117577 |
Bos taurus |
Osteoclast signaling |
https://identifiers.org/wikipathways/WP1007_r117578 |
Bos taurus |
Oxidation by cytochrome P450 |
https://identifiers.org/wikipathways/WP1077_r125262 |
Bos taurus |
Oxytocin signaling |
https://identifiers.org/wikipathways/WP3222_r116443 |
Bos taurus |
PDGF pathway |
https://identifiers.org/wikipathways/WP3200_r117588 |
Bos taurus |
Pathogenic Escherichia coli infection |
https://identifiers.org/wikipathways/WP3157_r80723 |
Bos taurus |
Pentose phosphate pathway |
https://identifiers.org/wikipathways/WP1028_r125261 |
Bos taurus |
Peptide GPCRs |
https://identifiers.org/wikipathways/WP1001_r115319 |
Bos taurus |
Peroxisomal beta-oxidation of tetracosanoyl-CoA |
https://identifiers.org/wikipathways/WP3146_r107060 |
Bos taurus |
Phase I biotransformations, non-P450 |
https://identifiers.org/wikipathways/WP1021_r128191 |
Bos taurus |
Pilocytic astrocytoma |
https://identifiers.org/wikipathways/WP3122_r105919 |
Bos taurus |
Regulation of toll-like receptor signaling pathway |
https://identifiers.org/wikipathways/WP3132_r80689 |
Bos taurus |
Retinoblastoma gene in cancer |
https://identifiers.org/wikipathways/WP3206_r120959 |
Bos taurus |
SIDS susceptibility pathways |
https://identifiers.org/wikipathways/WP3130_r128758 |
Bos taurus |
Selenium micronutrient network |
https://identifiers.org/wikipathways/WP3257_r120914 |
Bos taurus |
Serotonin receptor 2 and ELK-SRF / GATA4 signaling |
https://identifiers.org/wikipathways/WP3242_r125627 |
Bos taurus |
Serotonin receptor 2 and STAT3 signaling |
https://identifiers.org/wikipathways/WP3115_r125631 |
Bos taurus |
Serotonin receptor 4/6/7 and NR3C signaling |
https://identifiers.org/wikipathways/WP3272_r125632 |
Bos taurus |
Serotonin transporter activity |
https://identifiers.org/wikipathways/WP3138_r125666 |
Bos taurus |
Small ligand GPCRs |
https://identifiers.org/wikipathways/WP971_r117609 |
Bos taurus |
Steroid biosynthesis |
https://identifiers.org/wikipathways/WP1024_r121240 |
Bos taurus |
Striated muscle contraction |
https://identifiers.org/wikipathways/WP969_r117620 |
Bos taurus |
Synaptic vesicle pathway |
https://identifiers.org/wikipathways/WP3224_r117618 |
Bos taurus |
T cell receptor and co-stimulatory signaling |
https://identifiers.org/wikipathways/WP3282_r117615 |
Bos taurus |
TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) |
https://identifiers.org/wikipathways/WP3149_r117622 |
Bos taurus |
TCR signaling pathway |
https://identifiers.org/wikipathways/WP1011_r117623 |
Bos taurus |
TNF-alpha signaling pathway |
https://identifiers.org/wikipathways/WP1047_r116471 |
Bos taurus |
TSLP signaling pathway |
https://identifiers.org/wikipathways/WP3191_r117636 |
Bos taurus |
Toll-like receptor signaling pathway |
https://identifiers.org/wikipathways/WP1067_r122566 |
Bos taurus |
Trans-sulfuration pathway |
https://identifiers.org/wikipathways/WP3145_r80707 |
Bos taurus |
Triacylglyceride synthesis |
https://identifiers.org/wikipathways/WP1013_r120484 |
Bos taurus |
Tryptophan metabolism |
https://identifiers.org/wikipathways/WP3248_r105983 |
Bos taurus |
Type II diabetes mellitus |
https://identifiers.org/wikipathways/WP3117_r105918 |
Bos taurus |
Type III interferon signaling |
https://identifiers.org/wikipathways/WP3173_r86896 |
Bos taurus |
Urea cycle and metabolism of amino groups |
https://identifiers.org/wikipathways/WP3245_r123273 |
Bos taurus |
Vascular smooth muscle contraction |
https://identifiers.org/wikipathways/WP2912_r107057 |
Bos taurus |
Vitamin B12 metabolism |
https://identifiers.org/wikipathways/WP3193_r120912 |
Bos taurus |
Wnt signaling pathway and pluripotency |
https://identifiers.org/wikipathways/WP1010_r120483 |
Caenorhabditis elegans |
Biosynthesis and regulation of nematode bile acids |
https://identifiers.org/wikipathways/WP2293_r106026 |
Caenorhabditis elegans |
Cytoplasmic ribosomal proteins |
https://identifiers.org/wikipathways/WP540_r117042 |
Caenorhabditis elegans |
Dauer formation |
https://identifiers.org/wikipathways/WP580_r118394 |
Caenorhabditis elegans |
EGF signaling in vulval development |
https://identifiers.org/wikipathways/WP2221_r118368 |
Caenorhabditis elegans |
Fatty acid beta-oxidation meta-pathway |
https://identifiers.org/wikipathways/WP209_r118916 |
Caenorhabditis elegans |
Glycogen metabolism |
https://identifiers.org/wikipathways/WP436_r118434 |
Caenorhabditis elegans |
Heterchronic control of molting |
https://identifiers.org/wikipathways/WP2357_r118340 |
Caenorhabditis elegans |
Homologous recombination |
https://identifiers.org/wikipathways/WP741_r118328 |
Caenorhabditis elegans |
Metapathway signal transduction |
https://identifiers.org/wikipathways/WP1546_r126396 |
Caenorhabditis elegans |
Notch signaling in vulval development |
https://identifiers.org/wikipathways/WP2220_r118371 |
Caenorhabditis elegans |
Pentose phosphate pathway |
https://identifiers.org/wikipathways/WP312_r124579 |
Caenorhabditis elegans |
Proteasome degradation |
https://identifiers.org/wikipathways/WP470_r118348 |
Caenorhabditis elegans |
RNA interference and miRNA |
https://identifiers.org/wikipathways/WP394_r73143 |
Caenorhabditis elegans |
TOR signaling |
https://identifiers.org/wikipathways/WP1489_r126278 |
Caenorhabditis elegans |
Valine, leucine and isoleucine degradation |
https://identifiers.org/wikipathways/WP1451_r126324 |
Caenorhabditis elegans |
Vulval development and SynMuv |
https://identifiers.org/wikipathways/WP680_r118353 |
Caenorhabditis elegans |
Wnt signaling - Q neuroblast migration |
https://identifiers.org/wikipathways/WP2888_r118034 |
Caenorhabditis elegans |
Wnt signaling in cell polarity |
https://identifiers.org/wikipathways/WP2222_r118057 |
Canis familiaris |
Biogenic amine synthesis |
https://identifiers.org/wikipathways/WP1118_r117439 |
Canis familiaris |
Cell cycle |
https://identifiers.org/wikipathways/WP1200_r111030 |
Canis familiaris |
Delta-Notch signaling pathway |
https://identifiers.org/wikipathways/WP1180_r117992 |
Canis familiaris |
Electron transport chain |
https://identifiers.org/wikipathways/WP1119_r122664 |
Canis familiaris |
Glycogen metabolism |
https://identifiers.org/wikipathways/WP1189_r117452 |
Canis familiaris |
Heme biosynthesis |
https://identifiers.org/wikipathways/WP1086_r117457 |
Canis familiaris |
Homologous recombination |
https://identifiers.org/wikipathways/WP1153_r97063 |
Canis familiaris |
ID signaling pathway |
https://identifiers.org/wikipathways/WP1168_r120693 |
Canis familiaris |
Ketone bodies synthesis and degradation |
https://identifiers.org/wikipathways/WP1134_r117463 |
Canis familiaris |
Kit receptor signaling pathway |
https://identifiers.org/wikipathways/WP1121_r117459 |
Canis familiaris |
Monoamine GPCRs |
https://identifiers.org/wikipathways/WP1193_r106064 |
Canis familiaris |
Nuclear receptors in lipid metabolism and toxicity |
https://identifiers.org/wikipathways/WP1099_r107084 |
Canis familiaris |
Tryptophan metabolism |
https://identifiers.org/wikipathways/WP1126_r122665 |
Canis familiaris |
Wnt signaling pathway and pluripotency |
https://identifiers.org/wikipathways/WP1129_r117465 |
Caulobacter vibrioides |
Bacterial ceramide synthesis |
https://identifiers.org/wikipathways/WP5271_r123973 |
Danio rerio |
Apoptosis |
https://identifiers.org/wikipathways/WP1351_r95786 |
Danio rerio |
Biogenic amine synthesis |
https://identifiers.org/wikipathways/WP154_r116851 |
Danio rerio |
Cell cycle |
https://identifiers.org/wikipathways/WP1393_r111031 |
Danio rerio |
Cytoplasmic ribosomal proteins |
https://identifiers.org/wikipathways/WP324_r116855 |
Danio rerio |
Electron transport chain |
https://identifiers.org/wikipathways/WP1339_r122866 |
Danio rerio |
Estrogen signaling |
https://identifiers.org/wikipathways/WP1330_r116872 |
Danio rerio |
Exercise-induced circadian regulation |
https://identifiers.org/wikipathways/WP562_r116864 |
Danio rerio |
Glycogen metabolism |
https://identifiers.org/wikipathways/WP1388_r116877 |
Danio rerio |
IL-4 signaling pathway |
https://identifiers.org/wikipathways/WP1376_r117985 |
Danio rerio |
Mitochondrial long chain fatty acid beta-oxidation |
https://identifiers.org/wikipathways/WP498_r116891 |
Danio rerio |
Monoamine GPCRs |
https://identifiers.org/wikipathways/WP1389_r118402 |
Danio rerio |
Nuclear receptors in lipid metabolism and toxicity |
https://identifiers.org/wikipathways/WP1326_r107094 |
Danio rerio |
One-carbon metabolism |
https://identifiers.org/wikipathways/WP1355_r116584 |
Danio rerio |
Oxidative stress response |
https://identifiers.org/wikipathways/WP1372_r116901 |
Danio rerio |
Peptide GPCRs |
https://identifiers.org/wikipathways/WP1338_r88301 |
Danio rerio |
TCA cycle |
https://identifiers.org/wikipathways/WP19_r125413 |
Danio rerio |
Toll-like receptor signaling pathway |
https://identifiers.org/wikipathways/WP1384_r118905 |
Danio rerio |
Wnt Signaling Pathway and Pluripotency |
https://identifiers.org/wikipathways/WP1344_r115731 |
Danio rerio |
mRNA processing |
https://identifiers.org/wikipathways/WP467_r122797 |
Drosophila melanogaster |
Biogenic amine synthesis |
https://identifiers.org/wikipathways/WP125_r120778 |
Drosophila melanogaster |
Fatty acid beta-oxidation 1 |
https://identifiers.org/wikipathways/WP39_r124942 |
Drosophila melanogaster |
Fatty acid beta-oxidation 3 |
https://identifiers.org/wikipathways/WP25_r123859 |
Drosophila melanogaster |
Heme biosynthesis |
https://identifiers.org/wikipathways/WP269_r116923 |
Drosophila melanogaster |
Homologous recombination |
https://identifiers.org/wikipathways/WP1205_r116934 |
Drosophila melanogaster |
Mitochondrial long chain fatty acid beta-oxidation |
https://identifiers.org/wikipathways/WP406_r116926 |
Drosophila melanogaster |
Proteasome degradation |
https://identifiers.org/wikipathways/WP281_r116929 |
Drosophila melanogaster |
Translation factors |
https://identifiers.org/wikipathways/WP537_r116932 |
Drosophila melanogaster |
mRNA processing |
https://identifiers.org/wikipathways/WP142_r122788 |
Equus caballus |
Arylamine metabolism |
https://identifiers.org/wikipathways/WP1211_r106095 |
Equus caballus |
Metapathway biotransformation |
https://identifiers.org/wikipathways/WP1212_r87791 |
Equus caballus |
Phase I biotransformations, non-P450 |
https://identifiers.org/wikipathways/WP1213_r128193 |
Escherichia coli |
NAD biosynthesis I from aspartate |
https://identifiers.org/wikipathways/WP2484_r117436 |
Gallus gallus |
Apoptosis |
https://identifiers.org/wikipathways/WP787_r95787 |
Gallus gallus |
Cell cycle |
https://identifiers.org/wikipathways/WP844_r109474 |
Gallus gallus |
Chicken limb development |
https://identifiers.org/wikipathways/WP2587_r117081 |
Gallus gallus |
Delta-Notch signaling pathway |
https://identifiers.org/wikipathways/WP827_r117192 |
Gallus gallus |
Glycogen metabolism |
https://identifiers.org/wikipathways/WP835_r117200 |
Gallus gallus |
Homologous recombination |
https://identifiers.org/wikipathways/WP804_r119597 |
Gallus gallus |
Inhibitor of DNA binding (ID) signaling pathway |
https://identifiers.org/wikipathways/WP815_r117207 |
Gallus gallus |
Kit receptor signaling pathway |
https://identifiers.org/wikipathways/WP774_r117208 |
Gallus gallus |
Mitochondrial long chain fatty acid beta-oxidation |
https://identifiers.org/wikipathways/WP763_r117213 |
Gallus gallus |
Monoamine GPCRs |
https://identifiers.org/wikipathways/WP839_r106131 |
Gallus gallus |
Nuclear receptors in lipid metabolism and toxicity |
https://identifiers.org/wikipathways/WP755_r109452 |
Gallus gallus |
Regulation of actin cytoskeleton |
https://identifiers.org/wikipathways/WP824_r117210 |
Gallus gallus |
Triacylglyceride synthesis |
https://identifiers.org/wikipathways/WP782_r123954 |
Gallus gallus |
Wnt signaling pathway and pluripotency |
https://identifiers.org/wikipathways/WP779_r125337 |
Gibberella zeae |
DON mycotoxin biosynthesis |
https://identifiers.org/wikipathways/WP2258_r106133 |
Homo sapiens |
10q11.21q11.23 copy number variation syndrome |
https://identifiers.org/wikipathways/WP5352_r128797 |
Homo sapiens |
10q22q23 copy number variation |
https://identifiers.org/wikipathways/WP5402_r129008 |
Homo sapiens |
11p11.2 copy number variation syndrome |
https://identifiers.org/wikipathways/WP5348_r127123 |
Homo sapiens |
13q12 or CRYL1 copy number variation |
https://identifiers.org/wikipathways/WP5405_r127147 |
Homo sapiens |
13q12.12 copy number variation |
https://identifiers.org/wikipathways/WP5406_r127152 |
Homo sapiens |
15q11.2 copy number variation syndrome |
https://identifiers.org/wikipathways/WP4940_r124896 |
Homo sapiens |
15q11q13 copy number variation |
https://identifiers.org/wikipathways/WP5407_r129010 |
Homo sapiens |
15q13.3 copy number variation syndrome |
https://identifiers.org/wikipathways/WP4942_r115789 |
Homo sapiens |
15q25 copy number variation |
https://identifiers.org/wikipathways/WP5408_r129009 |
Homo sapiens |
16p11.2 distal deletion syndrome |
https://identifiers.org/wikipathways/WP4950_r128400 |
Homo sapiens |
16p11.2 proximal deletion syndrome |
https://identifiers.org/wikipathways/WP4949_r125693 |
Homo sapiens |
17p13.3 (YWHAE) copy number variation |
https://identifiers.org/wikipathways/WP5376_r127460 |
Homo sapiens |
17q12 copy number variation syndrome |
https://identifiers.org/wikipathways/WP5287_r126824 |
Homo sapiens |
22q11.2 copy number variation syndrome |
https://identifiers.org/wikipathways/WP4657_r128796 |
Homo sapiens |
3q29 copy number variation syndrome |
https://identifiers.org/wikipathways/WP4906_r129011 |
Homo sapiens |
4p16.3 copy number variation |
https://identifiers.org/wikipathways/WP5365_r127455 |
Homo sapiens |
5q35 copy number variation |
https://identifiers.org/wikipathways/WP5380_r127451 |
Homo sapiens |
6q16 copy number variation |
https://identifiers.org/wikipathways/WP5400_r127098 |
Homo sapiens |
7q11.23 copy number variation syndrome |
https://identifiers.org/wikipathways/WP4932_r126861 |
Homo sapiens |
7q11.23 distal copy number variation |
https://identifiers.org/wikipathways/WP5401_r127625 |
Homo sapiens |
8p23.1 copy number variation syndrome |
https://identifiers.org/wikipathways/WP5346_r127110 |
Homo sapiens |
ADHD and autism (ASD) linked metabolic pathways and SNP |
https://identifiers.org/wikipathways/WP5420_r128690 |
Homo sapiens |
AGE/RAGE pathway |
https://identifiers.org/wikipathways/WP2324_r126372 |
Homo sapiens |
AMP-activated protein kinase signaling |
https://identifiers.org/wikipathways/WP1403_r128119 |
Homo sapiens |
ATM signaling pathway |
https://identifiers.org/wikipathways/WP2516_r128135 |
Homo sapiens |
Abnormal calcium handling and its effects on muscle contraction in DMD |
https://identifiers.org/wikipathways/WP5343_r126461 |
Homo sapiens |
Acquired partial lipodystrophy / Barraquer-Simons syndrome |
https://identifiers.org/wikipathways/WP5104_r128462 |
Homo sapiens |
Acute viral myocarditis |
https://identifiers.org/wikipathways/WP4298_r128817 |
Homo sapiens |
Adverse outcome pathway for mitochondrial complex 1 (C1) inhibition |
https://identifiers.org/wikipathways/WP4914_r116532 |
Homo sapiens |
Aerobic glycolysis |
https://identifiers.org/wikipathways/WP4629_r129396 |
Homo sapiens |
Alstrom syndrome |
https://identifiers.org/wikipathways/WP5202_r128813 |
Homo sapiens |
Amino acid metabolism |
https://identifiers.org/wikipathways/WP3925_r123124 |
Homo sapiens |
Amino acid metabolism pathway excerpt: histidine catabolism extension |
https://identifiers.org/wikipathways/WP4661_r117646 |
Homo sapiens |
Androgen receptor network in prostate cancer |
https://identifiers.org/wikipathways/WP2263_r127838 |
Homo sapiens |
Angiogenesis |
https://identifiers.org/wikipathways/WP1539_r128558 |
Homo sapiens |
Angiopoietin-like protein 8 regulatory pathway |
https://identifiers.org/wikipathways/WP3915_r128129 |
Homo sapiens |
Angiotensin II receptor type 1 pathway |
https://identifiers.org/wikipathways/WP5036_r128622 |
Homo sapiens |
Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway |
https://identifiers.org/wikipathways/WP5113_r125765 |
Homo sapiens |
Apoptosis |
https://identifiers.org/wikipathways/WP254_r128148 |
Homo sapiens |
Arachidonic acid (AA, ARA) oxylipin metabolism |
https://identifiers.org/wikipathways/WP5155_r124435 |
Homo sapiens |
Arrhythmogenic right ventricular cardiomyopathy |
https://identifiers.org/wikipathways/WP2118_r119252 |
Homo sapiens |
Arsenic metabolism and reactive oxygen species generation |
https://identifiers.org/wikipathways/WP5233_r123583 |
Homo sapiens |
Aryl hydrocarbon receptor pathway |
https://identifiers.org/wikipathways/WP2586_r126477 |
Homo sapiens |
Aspirin and miRNAs |
https://identifiers.org/wikipathways/WP4707_r128647 |
Homo sapiens |
Autophagy in pancreatic ductal adenocarcinoma |
https://identifiers.org/wikipathways/WP5331_r126176 |
Homo sapiens |
Bardet-Biedl syndrome |
https://identifiers.org/wikipathways/WP5234_r123515 |
Homo sapiens |
Biogenic amine synthesis |
https://identifiers.org/wikipathways/WP550_r126245 |
Homo sapiens |
Biomarkers for pyrimidine metabolism disorders |
https://identifiers.org/wikipathways/WP4584_r123407 |
Homo sapiens |
Blood clotting and drug effects |
https://identifiers.org/wikipathways/WP4580_r123582 |
Homo sapiens |
Brain-derived neurotrophic factor (BDNF) signaling pathway |
https://identifiers.org/wikipathways/WP2380_r126377 |
Homo sapiens |
Burn wound healing |
https://identifiers.org/wikipathways/WP5055_r122621 |
Homo sapiens |
CAMKK2 pathway |
https://identifiers.org/wikipathways/WP4874_r126535 |
Homo sapiens |
CCL18 signaling pathway |
https://identifiers.org/wikipathways/WP5097_r126447 |
Homo sapiens |
COVID-19 adverse outcome pathway |
https://identifiers.org/wikipathways/WP4891_r120510 |
Homo sapiens |
COVID-19 and endothelial cell senescence |
https://identifiers.org/wikipathways/WP5256_r124640 |
Homo sapiens |
Cannabinoid receptor signaling |
https://identifiers.org/wikipathways/WP3869_r118463 |
Homo sapiens |
Cell differentiation - expanded index |
https://identifiers.org/wikipathways/WP2023_r117676 |
Homo sapiens |
Cerebral organic acidurias, including diseases |
https://identifiers.org/wikipathways/WP4519_r128195 |
Homo sapiens |
Chemokine signaling pathway |
https://identifiers.org/wikipathways/WP3929_r119247 |
Homo sapiens |
Cholestasis |
https://identifiers.org/wikipathways/WP5238_r127769 |
Homo sapiens |
Cholesterol synthesis disorders |
https://identifiers.org/wikipathways/WP5193_r128200 |
Homo sapiens |
Circadian rhythm genes |
https://identifiers.org/wikipathways/WP3594_r117682 |
Homo sapiens |
Clock-controlled autophagy in bone metabolism |
https://identifiers.org/wikipathways/WP5205_r122560 |
Homo sapiens |
Cohesin complex - Cornelia de Lange syndrome |
https://identifiers.org/wikipathways/WP5117_r129302 |
Homo sapiens |
Complement and coagulation cascades |
https://identifiers.org/wikipathways/WP558_r126246 |
Homo sapiens |
Complement system in neuronal development and plasticity |
https://identifiers.org/wikipathways/WP5090_r118898 |
Homo sapiens |
Congenital generalized lipodystrophy |
https://identifiers.org/wikipathways/WP5101_r123625 |
Homo sapiens |
Copper metabolism |
https://identifiers.org/wikipathways/WP5189_r128212 |
Homo sapiens |
Cori cycle |
https://identifiers.org/wikipathways/WP1946_r126409 |
Homo sapiens |
Corticotropin-releasing hormone signaling pathway |
https://identifiers.org/wikipathways/WP2355_r126374 |
Homo sapiens |
Creatine pathway |
https://identifiers.org/wikipathways/WP5190_r128231 |
Homo sapiens |
Cysteine and methionine catabolism |
https://identifiers.org/wikipathways/WP4504_r119316 |
Homo sapiens |
Cytoplasmic ribosomal proteins |
https://identifiers.org/wikipathways/WP477_r117044 |
Homo sapiens |
DNA adduct formation leading to kidney failure |
https://identifiers.org/wikipathways/WP5389_r126906 |
Homo sapiens |
DNA damage response (only ATM dependent) |
https://identifiers.org/wikipathways/WP710_r126217 |
Homo sapiens |
DYRK1A involvement regarding cell proliferation in brain development |
https://identifiers.org/wikipathways/WP5180_r126955 |
Homo sapiens |
Dengue-2 interactions with complement and coagulation cascades |
https://identifiers.org/wikipathways/WP3896_r129065 |
Homo sapiens |
Development of ureteric collection system |
https://identifiers.org/wikipathways/WP5053_r118778 |
Homo sapiens |
Diet-dependent trimethylamine/trimethylamine N-oxide metabolism |
https://identifiers.org/wikipathways/WP5219_r126795 |
Homo sapiens |
Direct reversal repair |
https://identifiers.org/wikipathways/WP4931_r117699 |
Homo sapiens |
Disorders in ketolysis |
https://identifiers.org/wikipathways/WP5195_r128225 |
Homo sapiens |
Docosahexaenoic acid oxylipin metabolism |
https://identifiers.org/wikipathways/WP5154_r123805 |
Homo sapiens |
Dopaminergic neurogenesis |
https://identifiers.org/wikipathways/WP2855_r126378 |
Homo sapiens |
Dravet syndrome |
https://identifiers.org/wikipathways/WP5200_r124413 |
Homo sapiens |
Drug induction of bile acid pathway |
https://identifiers.org/wikipathways/WP2289_r128660 |
Homo sapiens |
EGF/EGFR signaling pathway |
https://identifiers.org/wikipathways/WP437_r126309 |
Homo sapiens |
Ectoderm differentiation |
https://identifiers.org/wikipathways/WP2858_r116763 |
Homo sapiens |
Effect of progerin on genes involved in progeria |
https://identifiers.org/wikipathways/WP4320_r128823 |
Homo sapiens |
Endoderm differentiation |
https://identifiers.org/wikipathways/WP2853_r116557 |
Homo sapiens |
Endothelin pathways |
https://identifiers.org/wikipathways/WP2197_r117710 |
Homo sapiens |
Energy metabolism |
https://identifiers.org/wikipathways/WP1541_r126394 |
Homo sapiens |
Ethylmalonic encephalopathy |
https://identifiers.org/wikipathways/WP5030_r128249 |
Homo sapiens |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
https://identifiers.org/wikipathways/WP5218_r129276 |
Homo sapiens |
FOXP3 in COVID-19 |
https://identifiers.org/wikipathways/WP5063_r118833 |
Homo sapiens |
Familial hyperlipidemia type 1 |
https://identifiers.org/wikipathways/WP5108_r120390 |
Homo sapiens |
Familial hyperlipidemia type 2 |
https://identifiers.org/wikipathways/WP5109_r120391 |
Homo sapiens |
Familial hyperlipidemia type 3 |
https://identifiers.org/wikipathways/WP5110_r120392 |
Homo sapiens |
Familial hyperlipidemia type 4 |
https://identifiers.org/wikipathways/WP5111_r119173 |
Homo sapiens |
Familial hyperlipidemia type 5 |
https://identifiers.org/wikipathways/WP5112_r119153 |
Homo sapiens |
Familial partial lipodystrophy |
https://identifiers.org/wikipathways/WP5102_r123632 |
Homo sapiens |
Fatty acid beta-oxidation |
https://identifiers.org/wikipathways/WP143_r124923 |
Homo sapiens |
Fatty acid biosynthesis |
https://identifiers.org/wikipathways/WP357_r125347 |
Homo sapiens |
Fatty acid omega-oxidation |
https://identifiers.org/wikipathways/WP206_r117723 |
Homo sapiens |
Fatty acids and lipoproteins transport in hepatocytes |
https://identifiers.org/wikipathways/WP5323_r128432 |
Homo sapiens |
Female steroid hormones in cardiomyocyte energy metabolism |
https://identifiers.org/wikipathways/WP5318_r125826 |
Homo sapiens |
Fibrin complement receptor 3 signaling pathway |
https://identifiers.org/wikipathways/WP4136_r127352 |
Homo sapiens |
Flavan-3-ol metabolic pathway |
https://identifiers.org/wikipathways/WP4238_r125301 |
Homo sapiens |
Folate metabolism |
https://identifiers.org/wikipathways/WP176_r121696 |
Homo sapiens |
Fragile X syndrome |
https://identifiers.org/wikipathways/WP4549_r127643 |
Homo sapiens |
GABA receptor signaling |
https://identifiers.org/wikipathways/WP4159_r128692 |
Homo sapiens |
GDNF signaling |
https://identifiers.org/wikipathways/WP5143_r124544 |
Homo sapiens |
GPR143 in melanocytes and retinal pigment epithelium cells |
https://identifiers.org/wikipathways/WP4941_r120578 |
Homo sapiens |
GPR40 pathway |
https://identifiers.org/wikipathways/WP3958_r117148 |
Homo sapiens |
Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases |
https://identifiers.org/wikipathways/WP4518_r128245 |
Homo sapiens |
Gastric acid production |
https://identifiers.org/wikipathways/WP2596_r129122 |
Homo sapiens |
Genes controlling nephrogenesis |
https://identifiers.org/wikipathways/WP4823_r119116 |
Homo sapiens |
Genes targeted by miRNAs in adipocytes |
https://identifiers.org/wikipathways/WP1992_r105839 |
Homo sapiens |
Genetic causes of porto-sinusoidal vascular disease |
https://identifiers.org/wikipathways/WP5269_r128397 |
Homo sapiens |
Glial cell differentiation |
https://identifiers.org/wikipathways/WP2276_r129224 |
Homo sapiens |
Glycine metabolism |
https://identifiers.org/wikipathways/WP1495_r126384 |
Homo sapiens |
Glycolysis and gluconeogenesis |
https://identifiers.org/wikipathways/WP534_r128076 |
Homo sapiens |
Glycolysis in senescence |
https://identifiers.org/wikipathways/WP5049_r127659 |
Homo sapiens |
Glycosaminoglycan degradation |
https://identifiers.org/wikipathways/WP4815_r110276 |
Homo sapiens |
Glycosylation and related congenital defects |
https://identifiers.org/wikipathways/WP4521_r128247 |
Homo sapiens |
Glyoxylate metabolism |
https://identifiers.org/wikipathways/WP5166_r128248 |
Homo sapiens |
HDAC6 interactions in the central nervous system |
https://identifiers.org/wikipathways/WP5426_r128236 |
Homo sapiens |
HIF1A and PPARG regulation of glycolysis |
https://identifiers.org/wikipathways/WP2456_r119185 |
Homo sapiens |
Hair follicle development: organogenesis - part 2 of 3 |
https://identifiers.org/wikipathways/WP2839_r117746 |
Homo sapiens |
Hedgehog signaling pathway |
https://identifiers.org/wikipathways/WP4249_r127354 |
Homo sapiens |
Hematopoietic stem cell differentiation |
https://identifiers.org/wikipathways/WP2849_r129244 |
Homo sapiens |
Hemesynthesis defects and porphyrias |
https://identifiers.org/wikipathways/WP5169_r128214 |
Homo sapiens |
Histone modifications |
https://identifiers.org/wikipathways/WP2369_r128464 |
Homo sapiens |
Homologous recombination |
https://identifiers.org/wikipathways/WP186_r126268 |
Homo sapiens |
IL-19 signaling pathway |
https://identifiers.org/wikipathways/WP5422_r127701 |
Homo sapiens |
IL-26 signaling pathways |
https://identifiers.org/wikipathways/WP5347_r126468 |
Homo sapiens |
Inflammatory bowel disease signaling |
https://identifiers.org/wikipathways/WP5198_r129326 |
Homo sapiens |
Influence of laminopathies on Wnt signaling |
https://identifiers.org/wikipathways/WP4844_r128837 |
Homo sapiens |
Influenza A virus infection |
https://identifiers.org/wikipathways/WP1438_r108357 |
Homo sapiens |
Integrated cancer pathway |
https://identifiers.org/wikipathways/WP1971_r126414 |
Homo sapiens |
Interferon type I signaling pathways |
https://identifiers.org/wikipathways/WP585_r129287 |
Homo sapiens |
Interleukin-11 signaling pathway |
https://identifiers.org/wikipathways/WP2332_r126373 |
Homo sapiens |
Irinotecan pathway |
https://identifiers.org/wikipathways/WP229_r128658 |
Homo sapiens |
Iron metabolism disorders |
https://identifiers.org/wikipathways/WP5172_r128276 |
Homo sapiens |
Joubert syndrome |
https://identifiers.org/wikipathways/WP4656_r125785 |
Homo sapiens |
KCNQ2-related epilepsies |
https://identifiers.org/wikipathways/WP5360_r128048 |
Homo sapiens |
Ketogenesis and ketolysis |
https://identifiers.org/wikipathways/WP4742_r122056 |
Homo sapiens |
Kynurenine pathway and links to cell senescence |
https://identifiers.org/wikipathways/WP5044_r127649 |
Homo sapiens |
LDLRAD4 and what we know about it |
https://identifiers.org/wikipathways/WP4904_r124593 |
Homo sapiens |
Lac-Phe pathway |
https://identifiers.org/wikipathways/WP5239_r123034 |
Homo sapiens |
Leptin-insulin signaling overlap |
https://identifiers.org/wikipathways/WP3935_r118425 |
Homo sapiens |
Leucine, isoleucine and valine metabolism |
https://identifiers.org/wikipathways/WP4686_r128283 |
Homo sapiens |
Leukotriene metabolic pathway |
https://identifiers.org/wikipathways/WP5171_r125324 |
Homo sapiens |
Lidocaine metabolism |
https://identifiers.org/wikipathways/WP2646_r106722 |
Homo sapiens |
Linoleic acid metabolism affected by SARS-CoV-2 |
https://identifiers.org/wikipathways/WP4853_r128505 |
Homo sapiens |
Lipid particles composition |
https://identifiers.org/wikipathways/WP3601_r117687 |
Homo sapiens |
Liver steatosis adverse outcome pathway |
https://identifiers.org/wikipathways/WP4010_r128765 |
Homo sapiens |
MAPK pathway in congenital thyroid cancer |
https://identifiers.org/wikipathways/WP4928_r120795 |
Homo sapiens |
Macrophage markers |
https://identifiers.org/wikipathways/WP4146_r107552 |
Homo sapiens |
Macrophage-stimulating protein (MSP) signaling network map |
https://identifiers.org/wikipathways/WP5353_r128417 |
Homo sapiens |
Major receptors targeted by epinephrine and norepinephrine |
https://identifiers.org/wikipathways/WP4589_r127758 |
Homo sapiens |
Male steroid hormones in cardiomyocyte energy metabolism |
https://identifiers.org/wikipathways/WP5320_r125916 |
Homo sapiens |
Mammary gland development pathway - Involution (Stage 4 of 4) |
https://identifiers.org/wikipathways/WP2815_r128669 |
Homo sapiens |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
https://identifiers.org/wikipathways/WP2817_r128957 |
Homo sapiens |
Mammary gland development pathway - Puberty (Stage 2 of 4) |
https://identifiers.org/wikipathways/WP2814_r128676 |
Homo sapiens |
Markers of kidney cell lineage |
https://identifiers.org/wikipathways/WP5236_r129234 |
Homo sapiens |
Measles virus infection |
https://identifiers.org/wikipathways/WP4630_r129207 |
Homo sapiens |
Melatonin metabolism and effects |
https://identifiers.org/wikipathways/WP3298_r123268 |
Homo sapiens |
Mesodermal commitment pathway |
https://identifiers.org/wikipathways/WP2857_r118395 |
Homo sapiens |
Meta pathway lipodystrophy, dyslipidemia and hyperlipidemia |
https://identifiers.org/wikipathways/WP5105_r125316 |
Homo sapiens |
Metabolic Epileptic Disorders |
https://identifiers.org/wikipathways/WP5355_r127088 |
Homo sapiens |
Metabolic pathway of LDL, HDL and TG, including diseases |
https://identifiers.org/wikipathways/WP4522_r128956 |
Homo sapiens |
Metabolic reprogramming in colon cancer |
https://identifiers.org/wikipathways/WP4290_r118611 |
Homo sapiens |
Metabolism of alpha-linolenic acid |
https://identifiers.org/wikipathways/WP4586_r119267 |
Homo sapiens |
Metabolism overview |
https://identifiers.org/wikipathways/WP3602_r124180 |
Homo sapiens |
Metastatic brain tumor |
https://identifiers.org/wikipathways/WP2249_r107453 |
Homo sapiens |
Methionine metabolism leading to sulfur amino acids and related disorders |
https://identifiers.org/wikipathways/WP4292_r128219 |
Homo sapiens |
Mitochondrial beta-oxidation |
https://identifiers.org/wikipathways/WP5241_r124023 |
Homo sapiens |
Mitochondrial complex I inhibition leading to chemical-induced Fanconi syndrome |
https://identifiers.org/wikipathways/WP4944_r129304 |
Homo sapiens |
Mitochondrial complex inhibition leading to liver injury |
https://identifiers.org/wikipathways/WP5034_r129109 |
Homo sapiens |
Mitochondrial immune response to SARS-CoV-2 |
https://identifiers.org/wikipathways/WP5038_r129286 |
Homo sapiens |
Mitochondrial long chain fatty acid beta-oxidation |
https://identifiers.org/wikipathways/WP368_r126356 |
Homo sapiens |
Monoamine GPCRs |
https://identifiers.org/wikipathways/WP58_r128028 |
Homo sapiens |
Monoamine transport |
https://identifiers.org/wikipathways/WP727_r116775 |
Homo sapiens |
NAD biosynthesis II (from tryptophan) |
https://identifiers.org/wikipathways/WP2485_r117161 |
Homo sapiens |
NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence |
https://identifiers.org/wikipathways/WP5046_r118987 |
Homo sapiens |
NF1 copy number variation syndrome |
https://identifiers.org/wikipathways/WP5366_r129271 |
Homo sapiens |
NIPBL role in DNA damage - Cornelia de Lange syndrome |
https://identifiers.org/wikipathways/WP5119_r129305 |
Homo sapiens |
NO/cGMP/PKG mediated neuroprotection |
https://identifiers.org/wikipathways/WP4008_r125786 |
Homo sapiens |
NPHP1 deletion syndrome |
https://identifiers.org/wikipathways/WP5399_r127059 |
Homo sapiens |
NRP1-triggered signaling pathways in pancreatic cancer |
https://identifiers.org/wikipathways/WP5144_r129321 |
Homo sapiens |
NRXN1 deletion syndrome |
https://identifiers.org/wikipathways/WP5398_r127052 |
Homo sapiens |
Nephrogenesis |
https://identifiers.org/wikipathways/WP5052_r118777 |
Homo sapiens |
Network map of SARS-CoV-2 signaling pathway |
https://identifiers.org/wikipathways/WP5115_r126845 |
Homo sapiens |
Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway |
https://identifiers.org/wikipathways/WP4577_r128399 |
Homo sapiens |
Neurogenesis regulation in the olfactory epithelium |
https://identifiers.org/wikipathways/WP5265_r123524 |
Homo sapiens |
Neuroinflammation and glutamatergic signaling |
https://identifiers.org/wikipathways/WP5083_r120385 |
Homo sapiens |
Nicotine effect on chromaffin cells |
https://identifiers.org/wikipathways/WP1603_r126681 |
Homo sapiens |
Non-classical role of vitamin D |
https://identifiers.org/wikipathways/WP5133_r124643 |
Homo sapiens |
Nuclear receptors in lipid metabolism and toxicity |
https://identifiers.org/wikipathways/WP299_r126284 |
Homo sapiens |
Nucleotide GPCRs |
https://identifiers.org/wikipathways/WP80_r128041 |
Homo sapiens |
Nucleotide excision repair in xeroderma pigmentosum |
https://identifiers.org/wikipathways/WP5114_r119169 |
Homo sapiens |
Omega-6-fatty acids in senescence |
https://identifiers.org/wikipathways/WP5424_r129383 |
Homo sapiens |
One-carbon metabolism |
https://identifiers.org/wikipathways/WP241_r126998 |
Homo sapiens |
One-carbon metabolism and related pathways |
https://identifiers.org/wikipathways/WP3940_r119248 |
Homo sapiens |
Opioid receptor pathways |
https://identifiers.org/wikipathways/WP5093_r126328 |
Homo sapiens |
Orexin receptor pathway |
https://identifiers.org/wikipathways/WP5094_r126204 |
Homo sapiens |
Osteoblast signaling |
https://identifiers.org/wikipathways/WP322_r126329 |
Homo sapiens |
Ovarian infertility |
https://identifiers.org/wikipathways/WP34_r127999 |
Homo sapiens |
Overlap between signal transduction pathways contributing to LMNA laminopathies |
https://identifiers.org/wikipathways/WP4879_r128410 |
Homo sapiens |
Overview of interferons-mediated signaling pathway |
https://identifiers.org/wikipathways/WP4558_r107928 |
Homo sapiens |
Overview of nanoparticle effects |
https://identifiers.org/wikipathways/WP3287_r121705 |
Homo sapiens |
Oxidation by cytochrome P450 |
https://identifiers.org/wikipathways/WP43_r122562 |
Homo sapiens |
Oxidative damage response |
https://identifiers.org/wikipathways/WP3941_r123242 |
Homo sapiens |
Oxytocin signaling |
https://identifiers.org/wikipathways/WP2889_r107138 |
Homo sapiens |
PAFAH1B1 copy number variation |
https://identifiers.org/wikipathways/WP5409_r127181 |
Homo sapiens |
PDGF pathway |
https://identifiers.org/wikipathways/WP2526_r123068 |
Homo sapiens |
PGK1, PKM2, KHKC/KHKA acting as protein kinases |
https://identifiers.org/wikipathways/WP5433_r127841 |
Homo sapiens |
PTF1A related regulatory pathway |
https://identifiers.org/wikipathways/WP4147_r94394 |
Homo sapiens |
Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex |
https://identifiers.org/wikipathways/WP4884_r124646 |
Homo sapiens |
Pathophysiological roles of DUX4 in FSHD1 |
https://identifiers.org/wikipathways/WP5342_r126930 |
Homo sapiens |
Pathways in cancer |
https://identifiers.org/wikipathways/WP5434_r129136 |
Homo sapiens |
Pathways of nucleic acid metabolism and innate immune sensing |
https://identifiers.org/wikipathways/WP4705_r128779 |
Homo sapiens |
Pentose phosphate metabolism |
https://identifiers.org/wikipathways/WP134_r126271 |
Homo sapiens |
Peptide GPCRs |
https://identifiers.org/wikipathways/WP24_r126263 |
Homo sapiens |
Peroxisomal beta-oxidation of tetracosanoyl-CoA |
https://identifiers.org/wikipathways/WP1941_r126408 |
Homo sapiens |
Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins |
https://identifiers.org/wikipathways/WP4936_r124645 |
Homo sapiens |
Phase I biotransformations, non-P450 |
https://identifiers.org/wikipathways/WP136_r128192 |
Homo sapiens |
Primary ovarian insufficiency |
https://identifiers.org/wikipathways/WP5316_r127621 |
Homo sapiens |
Prion disease pathway |
https://identifiers.org/wikipathways/WP3995_r128423 |
Homo sapiens |
Progeria-associated lipodystrophy |
https://identifiers.org/wikipathways/WP5103_r119170 |
Homo sapiens |
Prolactin signaling pathway |
https://identifiers.org/wikipathways/WP2037_r126350 |
Homo sapiens |
Proline and hydroxyproline pathways |
https://identifiers.org/wikipathways/WP5026_r128194 |
Homo sapiens |
Prostaglandin and leukotriene metabolism in senescence |
https://identifiers.org/wikipathways/WP5122_r119484 |
Homo sapiens |
Prostaglandin and leukotriene metabolism in senescence |
https://identifiers.org/wikipathways/WP5321_r125240 |
Homo sapiens |
Proximal tubule transport |
https://identifiers.org/wikipathways/WP4917_r119111 |
Homo sapiens |
PtdIns(4,5)P2 in cytokinesis pathway |
https://identifiers.org/wikipathways/WP5199_r125330 |
Homo sapiens |
Purine metabolism |
https://identifiers.org/wikipathways/WP4792_r124888 |
Homo sapiens |
Purine metabolism and related disorders |
https://identifiers.org/wikipathways/WP4224_r128217 |
Homo sapiens |
Purinergic signaling |
https://identifiers.org/wikipathways/WP4900_r123440 |
Homo sapiens |
Pyrimidine metabolism |
https://identifiers.org/wikipathways/WP4022_r126316 |
Homo sapiens |
Pyrimidine metabolism and related diseases |
https://identifiers.org/wikipathways/WP4225_r128218 |
Homo sapiens |
RANKL/RANK signaling pathway |
https://identifiers.org/wikipathways/WP2018_r126338 |
Homo sapiens |
Ras signaling |
https://identifiers.org/wikipathways/WP4223_r127495 |
Homo sapiens |
Renin-angiotensin-aldosterone system (RAAS) |
https://identifiers.org/wikipathways/WP4756_r127761 |
Homo sapiens |
Retinoblastoma gene in cancer |
https://identifiers.org/wikipathways/WP2446_r116593 |
Homo sapiens |
Rett syndrome |
https://identifiers.org/wikipathways/WP4312_r128465 |
Homo sapiens |
Riboflavin and CoQ disorders |
https://identifiers.org/wikipathways/WP5037_r128507 |
Homo sapiens |
Rubinstein-Taybi syndrome 1 |
https://identifiers.org/wikipathways/WP5367_r129307 |
Homo sapiens |
SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation |
https://identifiers.org/wikipathways/WP5116_r125318 |
Homo sapiens |
SARS-CoV-2 altering angiogenesis via NRP1 |
https://identifiers.org/wikipathways/WP5065_r124651 |
Homo sapiens |
SARS-CoV-2 and COVID-19 pathway |
https://identifiers.org/wikipathways/WP4846_r120585 |
Homo sapiens |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
https://identifiers.org/wikipathways/WP5039_r125309 |
Homo sapiens |
SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction |
https://identifiers.org/wikipathways/WP5183_r124655 |
Homo sapiens |
SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome |
https://identifiers.org/wikipathways/WP5118_r129308 |
Homo sapiens |
SRF and miRs in smooth muscle differentiation and proliferation |
https://identifiers.org/wikipathways/WP1991_r117830 |
Homo sapiens |
Sebaleic acid formation and metabolism |
https://identifiers.org/wikipathways/WP5315_r125120 |
Homo sapiens |
Secretion of hydrochloric acid in parietal cells |
https://identifiers.org/wikipathways/WP2597_r129119 |
Homo sapiens |
Selenium micronutrient network |
https://identifiers.org/wikipathways/WP15_r125000 |
Homo sapiens |
Serine metabolism |
https://identifiers.org/wikipathways/WP4688_r120418 |
Homo sapiens |
Serotonin HTR1 group and FOS pathway |
https://identifiers.org/wikipathways/WP722_r125764 |
Homo sapiens |
Serotonin and anxiety-related events |
https://identifiers.org/wikipathways/WP3944_r129057 |
Homo sapiens |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
https://identifiers.org/wikipathways/WP732_r125659 |
Homo sapiens |
Serotonin receptor 4/6/7 and NR3C signaling |
https://identifiers.org/wikipathways/WP734_r125662 |
Homo sapiens |
Serotonin transporter activity |
https://identifiers.org/wikipathways/WP1455_r126351 |
Homo sapiens |
Sildenafil treatment |
https://identifiers.org/wikipathways/WP5294_r127362 |
Homo sapiens |
Sleep regulation |
https://identifiers.org/wikipathways/WP3591_r88424 |
Homo sapiens |
Small ligand GPCRs |
https://identifiers.org/wikipathways/WP247_r126341 |
Homo sapiens |
Smith-Magenis and Potocki-Lupski syndrome copy number variation |
https://identifiers.org/wikipathways/WP5381_r127624 |
Homo sapiens |
Spina bifida |
https://identifiers.org/wikipathways/WP5150_r128047 |
Homo sapiens |
Striated muscle contraction pathway |
https://identifiers.org/wikipathways/WP383_r128580 |
Homo sapiens |
Sudden infant death syndrome (SIDS) susceptibility pathways |
https://identifiers.org/wikipathways/WP706_r129309 |
Homo sapiens |
Synaptic vesicle pathway |
https://identifiers.org/wikipathways/WP2267_r128068 |
Homo sapiens |
Synthesis of ceramides and 1-deoxyceramides |
https://identifiers.org/wikipathways/WP5194_r122165 |
Homo sapiens |
T cell receptor and co-stimulatory signaling |
https://identifiers.org/wikipathways/WP2583_r117181 |
Homo sapiens |
T-cell activation SARS-CoV-2 |
https://identifiers.org/wikipathways/WP5098_r129246 |
Homo sapiens |
T-cell receptor signaling pathway |
https://identifiers.org/wikipathways/WP69_r126222 |
Homo sapiens |
TAR syndrome |
https://identifiers.org/wikipathways/WP5362_r127046 |
Homo sapiens |
TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) |
https://identifiers.org/wikipathways/WP2453_r123103 |
Homo sapiens |
TNF-alpha signaling pathway |
https://identifiers.org/wikipathways/WP231_r124583 |
Homo sapiens |
TP53 network |
https://identifiers.org/wikipathways/WP1742_r126403 |
Homo sapiens |
TROP2 regulatory signaling |
https://identifiers.org/wikipathways/WP5300_r126494 |
Homo sapiens |
Th17 cell differentiation pathway |
https://identifiers.org/wikipathways/WP5130_r126092 |
Homo sapiens |
Thermogenesis |
https://identifiers.org/wikipathways/WP4321_r123362 |
Homo sapiens |
Thiamine metabolic pathways |
https://identifiers.org/wikipathways/WP4297_r129257 |
Homo sapiens |
Thymic stromal lymphopoietin (TSLP) signaling pathway |
https://identifiers.org/wikipathways/WP2203_r126371 |
Homo sapiens |
Thyroid hormones production and peripheral downstream signaling effects |
https://identifiers.org/wikipathways/WP4746_r128791 |
Homo sapiens |
Toll-like receptor signaling pathway |
https://identifiers.org/wikipathways/WP75_r128034 |
Homo sapiens |
Trans-sulfuration pathway |
https://identifiers.org/wikipathways/WP2333_r72015 |
Homo sapiens |
Transcription factor regulation in adipogenesis |
https://identifiers.org/wikipathways/WP3599_r105845 |
Homo sapiens |
Transcription factors regulate miRNAs related to cardiac hypertrophy |
https://identifiers.org/wikipathways/WP1559_r126397 |
Homo sapiens |
Triacylglyceride synthesis |
https://identifiers.org/wikipathways/WP325_r126355 |
Homo sapiens |
Type III interferon signaling |
https://identifiers.org/wikipathways/WP2113_r105848 |
Homo sapiens |
Tyrosine metabolism and related disorders |
https://identifiers.org/wikipathways/WP4506_r128203 |
Homo sapiens |
Urea cycle and associated pathways |
https://identifiers.org/wikipathways/WP4595_r128208 |
Homo sapiens |
Urea cycle and metabolism of amino groups |
https://identifiers.org/wikipathways/WP497_r119105 |
Homo sapiens |
Urotensin-II-mediated signaling pathway |
https://identifiers.org/wikipathways/WP5158_r126484 |
Homo sapiens |
VEGFA-VEGFR2 signaling |
https://identifiers.org/wikipathways/WP3888_r126337 |
Homo sapiens |
Vitamin B12 disorders |
https://identifiers.org/wikipathways/WP4271_r128221 |
Homo sapiens |
Vitamin B12 metabolism |
https://identifiers.org/wikipathways/WP1533_r121695 |
Homo sapiens |
Wnt signaling pathway and pluripotency |
https://identifiers.org/wikipathways/WP399_r119242 |
Homo sapiens |
Zinc homeostasis |
https://identifiers.org/wikipathways/WP3529_r120882 |
Homo sapiens |
miRNAs involved in DNA damage response |
https://identifiers.org/wikipathways/WP1545_r118363 |
Mus musculus |
Lipids measured in liver metastasis from breast cancer |
https://identifiers.org/wikipathways/WP4627_r129311 |
Mus musculus |
Alanine and aspartate metabolism |
https://identifiers.org/wikipathways/WP240_r124585 |
Mus musculus |
Alpha 6 beta 4 integrin signaling pathway |
https://identifiers.org/wikipathways/WP488_r117859 |
Mus musculus |
Amino acid conjugation of benzoic acid |
https://identifiers.org/wikipathways/WP1252_r106841 |
Mus musculus |
Amino acid metabolism |
https://identifiers.org/wikipathways/WP662_r122074 |
Mus musculus |
Apoptosis |
https://identifiers.org/wikipathways/WP1254_r95784 |
Mus musculus |
Apoptosis modulation by HSP70 |
https://identifiers.org/wikipathways/WP166_r117860 |
Mus musculus |
BDNF pathway |
https://identifiers.org/wikipathways/WP2152_r120589 |
Mus musculus |
Biogenic amine synthesis |
https://identifiers.org/wikipathways/WP522_r116829 |
Mus musculus |
Burn wound healing |
https://identifiers.org/wikipathways/WP5056_r119775 |
Mus musculus |
Chemokine signaling pathway |
https://identifiers.org/wikipathways/WP2292_r97515 |
Mus musculus |
Complement activation, classical pathway |
https://identifiers.org/wikipathways/WP200_r117868 |
Mus musculus |
Cytoplasmic ribosomal proteins |
https://identifiers.org/wikipathways/WP163_r117051 |
Mus musculus |
Delta-Notch signaling pathway |
https://identifiers.org/wikipathways/WP265_r117870 |
Mus musculus |
Dopaminergic neurogenesis |
https://identifiers.org/wikipathways/WP1498_r126387 |
Mus musculus |
Dravet syndrome: Scn1a-A1783V point mutation model |
https://identifiers.org/wikipathways/WP5298_r124558 |
Mus musculus |
Eicosanoid lipid synthesis map |
https://identifiers.org/wikipathways/WP4335_r117875 |
Mus musculus |
Electron transport chain |
https://identifiers.org/wikipathways/WP295_r117879 |
Mus musculus |
ErbB signaling pathway |
https://identifiers.org/wikipathways/WP1261_r108380 |
Mus musculus |
Estrogen signaling |
https://identifiers.org/wikipathways/WP1244_r114031 |
Mus musculus |
Fatty acid beta-oxidation |
https://identifiers.org/wikipathways/WP1269_r124924 |
Mus musculus |
Fatty acid biosynthesis |
https://identifiers.org/wikipathways/WP336_r125350 |
Mus musculus |
Fatty acid omega-oxidation |
https://identifiers.org/wikipathways/WP33_r124578 |
Mus musculus |
Fatty acid oxidation |
https://identifiers.org/wikipathways/WP2318_r106871 |
Mus musculus |
Fibrin complement receptor 3 signaling pathway |
https://identifiers.org/wikipathways/WP5128_r120386 |
Mus musculus |
Folic acid network |
https://identifiers.org/wikipathways/WP1273_r125270 |
Mus musculus |
GPCRs, class B secretin-like |
https://identifiers.org/wikipathways/WP456_r117890 |
Mus musculus |
GPCRs, class C metabotropic glutamate, pheromone |
https://identifiers.org/wikipathways/WP327_r117891 |
Mus musculus |
GPCRs, non-odorant |
https://identifiers.org/wikipathways/WP1396_r117923 |
Mus musculus |
GPCRs, odorant |
https://identifiers.org/wikipathways/WP1397_r117924 |
Mus musculus |
GPCRs, orphan |
https://identifiers.org/wikipathways/WP1398_r117933 |
Mus musculus |
GPCRs, peptide |
https://identifiers.org/wikipathways/WP234_r117936 |
Mus musculus |
GPCRs, small ligand |
https://identifiers.org/wikipathways/WP353_r117944 |
Mus musculus |
Glutathione and one-carbon metabolism |
https://identifiers.org/wikipathways/WP730_r116583 |
Mus musculus |
Glutathione metabolism |
https://identifiers.org/wikipathways/WP164_r106858 |
Mus musculus |
Glycogen metabolism |
https://identifiers.org/wikipathways/WP317_r121826 |
Mus musculus |
Glycolysis and gluconeogenesis |
https://identifiers.org/wikipathways/WP157_r116837 |
Mus musculus |
Heme biosynthesis |
https://identifiers.org/wikipathways/WP18_r124937 |
Mus musculus |
Histone modifications |
https://identifiers.org/wikipathways/WP300_r71890 |
Mus musculus |
Homologous recombination |
https://identifiers.org/wikipathways/WP1258_r69162 |
Mus musculus |
Hypoxia-dependent differentiation of myoblasts |
https://identifiers.org/wikipathways/WP5025_r128730 |
Mus musculus |
Hypoxia-dependent proliferation of myoblasts |
https://identifiers.org/wikipathways/WP5024_r119059 |
Mus musculus |
Hypoxia-dependent self-renewal of myoblasts |
https://identifiers.org/wikipathways/WP5023_r128731 |
Mus musculus |
ID signaling pathway |
https://identifiers.org/wikipathways/WP512_r120690 |
Mus musculus |
IL-1 signaling pathway |
https://identifiers.org/wikipathways/WP37_r117902 |
Mus musculus |
IL-2 signaling pathway |
https://identifiers.org/wikipathways/WP450_r117903 |
Mus musculus |
IL-3 signaling pathway |
https://identifiers.org/wikipathways/WP373_r117904 |
Mus musculus |
IL-5 signaling pathway |
https://identifiers.org/wikipathways/WP151_r117905 |
Mus musculus |
IL-6 signaling pathway |
https://identifiers.org/wikipathways/WP387_r117906 |
Mus musculus |
IL-7 signaling pathway |
https://identifiers.org/wikipathways/WP297_r117907 |
Mus musculus |
IL-9 signaling pathway |
https://identifiers.org/wikipathways/WP10_r125619 |
Mus musculus |
Inflammatory response pathway |
https://identifiers.org/wikipathways/WP458_r117908 |
Mus musculus |
Insulin signaling |
https://identifiers.org/wikipathways/WP65_r128033 |
Mus musculus |
Iron homeostasis |
https://identifiers.org/wikipathways/WP1596_r126400 |
Mus musculus |
Kit receptor signaling pathway |
https://identifiers.org/wikipathways/WP407_r117910 |
Mus musculus |
Lac-Phe pathway |
https://identifiers.org/wikipathways/WP5240_r124561 |
Mus musculus |
Leptin-insulin signaling overlap |
https://identifiers.org/wikipathways/WP578_r116798 |
Mus musculus |
Macrophage markers |
https://identifiers.org/wikipathways/WP2271_r69962 |
Mus musculus |
Mechanisms associated with pluripotency |
https://identifiers.org/wikipathways/WP1763_r126404 |
Mus musculus |
Metapathway biotransformation |
https://identifiers.org/wikipathways/WP1251_r94721 |
Mus musculus |
Mitochondrial long chain fatty acid beta-oxidation |
https://identifiers.org/wikipathways/WP401_r117919 |
Mus musculus |
Monoamine GPCRs |
https://identifiers.org/wikipathways/WP570_r106904 |
Mus musculus |
Non-homologous end joining |
https://identifiers.org/wikipathways/WP1242_r69140 |
Mus musculus |
Nuclear receptors in lipid metabolism and toxicity |
https://identifiers.org/wikipathways/WP431_r107205 |
Mus musculus |
Nucleotide GPCRs |
https://identifiers.org/wikipathways/WP207_r106865 |
Mus musculus |
One-carbon metabolism |
https://identifiers.org/wikipathways/WP435_r116571 |
Mus musculus |
One-carbon metabolism and related pathways |
https://identifiers.org/wikipathways/WP1770_r116575 |
Mus musculus |
Osteoblast signaling |
https://identifiers.org/wikipathways/WP238_r117579 |
Mus musculus |
Osteoclast signaling |
https://identifiers.org/wikipathways/WP454_r117932 |
Mus musculus |
Ovarian infertility |
https://identifiers.org/wikipathways/WP273_r118921 |
Mus musculus |
Oxidation by cytochrome P450 |
https://identifiers.org/wikipathways/WP1274_r125273 |
Mus musculus |
Oxidative damage response |
https://identifiers.org/wikipathways/WP1496_r126385 |
Mus musculus |
Oxidative stress response |
https://identifiers.org/wikipathways/WP412_r117038 |
Mus musculus |
Pentose phosphate pathway |
https://identifiers.org/wikipathways/WP63_r117935 |
Mus musculus |
Ptf1a related regulatory pathway |
https://identifiers.org/wikipathways/WP201_r109433 |
Mus musculus |
Purine metabolism |
https://identifiers.org/wikipathways/WP2185_r125281 |
Mus musculus |
Regulation of Pgc1a expression by a Gsk3b-Tfeb signaling axis in skeletal muscle |
https://identifiers.org/wikipathways/WP4763_r108519 |
Mus musculus |
Regulation of actin cytoskeleton |
https://identifiers.org/wikipathways/WP523_r120790 |
Mus musculus |
SIDS susceptibility pathways |
https://identifiers.org/wikipathways/WP1266_r117943 |
Mus musculus |
Selenium metabolism / selenoproteins |
https://identifiers.org/wikipathways/WP108_r117940 |
Mus musculus |
Selenium micronutrient network |
https://identifiers.org/wikipathways/WP1272_r120916 |
Mus musculus |
Serotonin and anxiety-related events |
https://identifiers.org/wikipathways/WP2140_r106868 |
Mus musculus |
Serotonin receptor 2 and STAT3 signaling |
https://identifiers.org/wikipathways/WP2079_r125629 |
Mus musculus |
Signal transduction of S1P receptor |
https://identifiers.org/wikipathways/WP57_r117945 |
Mus musculus |
Steroid biosynthesis |
https://identifiers.org/wikipathways/WP55_r128026 |
Mus musculus |
TCA cycle |
https://identifiers.org/wikipathways/WP434_r117949 |
Mus musculus |
Toll-like receptor signaling |
https://identifiers.org/wikipathways/WP88_r116521 |
Mus musculus |
Translation factors |
https://identifiers.org/wikipathways/WP307_r117950 |
Mus musculus |
Triacylglyceride synthesis |
https://identifiers.org/wikipathways/WP386_r121829 |
Mus musculus |
Tryptophan metabolism |
https://identifiers.org/wikipathways/WP79_r128037 |
Mus musculus |
Wnt signaling pathway |
https://identifiers.org/wikipathways/WP539_r120581 |
Mus musculus |
Wnt signaling pathway and pluripotency |
https://identifiers.org/wikipathways/WP723_r117953 |
Mus musculus |
mRNA processing |
https://identifiers.org/wikipathways/WP310_r122791 |
Mycobacterium tuberculosis |
Biotin metabolism |
https://identifiers.org/wikipathways/WP1631_r128405 |
Mycobacterium tuberculosis |
D-arginine and D-ornithine metabolism |
https://identifiers.org/wikipathways/WP1642_r126822 |
Mycobacterium tuberculosis |
Histidine metabolism |
https://identifiers.org/wikipathways/WP1581_r115241 |
Mycobacterium tuberculosis |
TCA cycle |
https://identifiers.org/wikipathways/WP2563_r87715 |
Mycobacterium tuberculosis |
Transcription initiation by sigma factors |
https://identifiers.org/wikipathways/WP2564_r122569 |
Oryza sativa |
Beta-alanine biosynthesis |
https://identifiers.org/wikipathways/WP2207_r117414 |
Oryza sativa |
Methylerythritol phosphate pathway |
https://identifiers.org/wikipathways/WP2212_r123064 |
Oryza sativa |
Seed development |
https://identifiers.org/wikipathways/WP2199_r125282 |
Pan troglodytes |
Apoptosis modulation by HSP70 |
https://identifiers.org/wikipathways/WP963_r117082 |
Pan troglodytes |
Cell cycle |
https://identifiers.org/wikipathways/WP964_r111047 |
Pan troglodytes |
Delta-Notch signaling pathway |
https://identifiers.org/wikipathways/WP946_r117386 |
Pan troglodytes |
Fatty acid omega-oxidation |
https://identifiers.org/wikipathways/WP852_r117392 |
Pan troglodytes |
Glycogen metabolism |
https://identifiers.org/wikipathways/WP955_r117395 |
Pan troglodytes |
Heme biosynthesis |
https://identifiers.org/wikipathways/WP848_r117403 |
Pan troglodytes |
Hepatocyte growth factor receptor signaling |
https://identifiers.org/wikipathways/WP927_r118823 |
Pan troglodytes |
Homologous recombination |
https://identifiers.org/wikipathways/WP917_r69316 |
Pan troglodytes |
ID signaling pathway |
https://identifiers.org/wikipathways/WP934_r120691 |
Pan troglodytes |
Kit receptor signaling pathway |
https://identifiers.org/wikipathways/WP886_r117405 |
Pan troglodytes |
Monoamine GPCRs |
https://identifiers.org/wikipathways/WP957_r106945 |
Pan troglodytes |
Nuclear receptors in lipid metabolism and toxicity |
https://identifiers.org/wikipathways/WP863_r109476 |
Pan troglodytes |
Osteoblast signaling |
https://identifiers.org/wikipathways/WP956_r117583 |
Pan troglodytes |
Osteoclast signaling |
https://identifiers.org/wikipathways/WP890_r125516 |
Rattus norvegicus |
ATM signaling pathway |
https://identifiers.org/wikipathways/WP654_r125336 |
Rattus norvegicus |
Amino acid conjugation of benzoic acid |
https://identifiers.org/wikipathways/WP1287_r106953 |
Rattus norvegicus |
Angiotensin II signaling (acute) in thick ascending limbs |
https://identifiers.org/wikipathways/WP3887_r107039 |
Rattus norvegicus |
Apoptosis |
https://identifiers.org/wikipathways/WP1290_r95785 |
Rattus norvegicus |
Beta-oxidation meta-pathway |
https://identifiers.org/wikipathways/WP372_r118914 |
Rattus norvegicus |
Beta-oxidation of unsaturated fatty acids |
https://identifiers.org/wikipathways/WP418_r118918 |
Rattus norvegicus |
Biosynthesis of aldosterone and cortisol |
https://identifiers.org/wikipathways/WP508_r116943 |
Rattus norvegicus |
Burn wound healing |
https://identifiers.org/wikipathways/WP5057_r125312 |
Rattus norvegicus |
Cardiovascular signaling |
https://identifiers.org/wikipathways/WP590_r116946 |
Rattus norvegicus |
Catecholamine synthesis |
https://identifiers.org/wikipathways/WP513_r125322 |
Rattus norvegicus |
Complement and coagulation cascades |
https://identifiers.org/wikipathways/WP547_r116949 |
Rattus norvegicus |
ErbB signaling pathway |
https://identifiers.org/wikipathways/WP1299_r108381 |
Rattus norvegicus |
Estrogen signaling |
https://identifiers.org/wikipathways/WP1279_r106948 |
Rattus norvegicus |
Fatty acid biosynthesis |
https://identifiers.org/wikipathways/WP504_r125345 |
Rattus norvegicus |
Fatty acid omega-oxidation |
https://identifiers.org/wikipathways/WP133_r116963 |
Rattus norvegicus |
Folic acid network |
https://identifiers.org/wikipathways/WP1311_r125276 |
Rattus norvegicus |
GPCRs, class A rhodopsin-like |
https://identifiers.org/wikipathways/WP473_r125508 |
Rattus norvegicus |
GPCRs, class B secretin-like |
https://identifiers.org/wikipathways/WP378_r116971 |
Rattus norvegicus |
GPCRs, other |
https://identifiers.org/wikipathways/WP409_r116975 |
Rattus norvegicus |
Glucocorticoid metabolism |
https://identifiers.org/wikipathways/WP305_r116969 |
Rattus norvegicus |
Glutathione metabolism |
https://identifiers.org/wikipathways/WP469_r104998 |
Rattus norvegicus |
Glycogen metabolism |
https://identifiers.org/wikipathways/WP160_r116973 |
Rattus norvegicus |
Heme biosynthesis |
https://identifiers.org/wikipathways/WP86_r116978 |
Rattus norvegicus |
Hepatocyte growth factor receptor signaling |
https://identifiers.org/wikipathways/WP94_r118829 |
Rattus norvegicus |
Homologous recombination |
https://identifiers.org/wikipathways/WP1296_r69445 |
Rattus norvegicus |
ID signaling pathway |
https://identifiers.org/wikipathways/WP397_r120694 |
Rattus norvegicus |
IL-1 signaling pathway |
https://identifiers.org/wikipathways/WP355_r116981 |
Rattus norvegicus |
IL-3 signaling pathway |
https://identifiers.org/wikipathways/WP319_r116984 |
Rattus norvegicus |
IL-5 signaling pathway |
https://identifiers.org/wikipathways/WP44_r116985 |
Rattus norvegicus |
IL-6 signaling pathway |
https://identifiers.org/wikipathways/WP135_r125589 |
Rattus norvegicus |
IL-9 signaling pathway |
https://identifiers.org/wikipathways/WP8_r116988 |
Rattus norvegicus |
Inflammatory response pathway |
https://identifiers.org/wikipathways/WP40_r128001 |
Rattus norvegicus |
Intracellular trafficking of CFTR |
https://identifiers.org/wikipathways/WP1486_r126275 |
Rattus norvegicus |
Kit receptor signaling pathway |
https://identifiers.org/wikipathways/WP147_r116983 |
Rattus norvegicus |
Metapathway biotransformation |
https://identifiers.org/wikipathways/WP1286_r125510 |
Rattus norvegicus |
Monoamine GPCRs |
https://identifiers.org/wikipathways/WP276_r106973 |
Rattus norvegicus |
Non-homologous end joining |
https://identifiers.org/wikipathways/WP1277_r69423 |
Rattus norvegicus |
Nuclear factor, erythroid-derived 2, like 2 signaling pathway |
https://identifiers.org/wikipathways/WP2376_r125515 |
Rattus norvegicus |
Nuclear receptors in lipid metabolism and toxicity |
https://identifiers.org/wikipathways/WP139_r107234 |
Rattus norvegicus |
Nucleotide GPCRs |
https://identifiers.org/wikipathways/WP502_r72163 |
Rattus norvegicus |
Nucleotide metabolism |
https://identifiers.org/wikipathways/WP146_r116996 |
Rattus norvegicus |
Osteoclast |
https://identifiers.org/wikipathways/WP489_r117034 |
Rattus norvegicus |
Oxidative stress response |
https://identifiers.org/wikipathways/WP173_r116998 |
Rattus norvegicus |
Pentose phosphate pathway |
https://identifiers.org/wikipathways/WP282_r125289 |
Rattus norvegicus |
Peptide GPCRs |
https://identifiers.org/wikipathways/WP131_r71770 |
Rattus norvegicus |
Phase I biotransformations, non-P450 |
https://identifiers.org/wikipathways/WP1291_r128190 |
Rattus norvegicus |
Prostaglandin synthesis and regulation |
https://identifiers.org/wikipathways/WP303_r117006 |
Rattus norvegicus |
Regulation of actin cytoskeleton |
https://identifiers.org/wikipathways/WP351_r117008 |
Rattus norvegicus |
Relationship between glutathione and NADPH |
https://identifiers.org/wikipathways/WP2562_r106972 |
Rattus norvegicus |
Renin-angiotensin system |
https://identifiers.org/wikipathways/WP376_r116622 |
Rattus norvegicus |
Selenium micronutrient network |
https://identifiers.org/wikipathways/WP1310_r120918 |
Rattus norvegicus |
Serotonin and anxiety |
https://identifiers.org/wikipathways/WP2132_r107237 |
Rattus norvegicus |
Small ligand GPCRs |
https://identifiers.org/wikipathways/WP161_r117014 |
Rattus norvegicus |
Steroid biosynthesis |
https://identifiers.org/wikipathways/WP66_r117016 |
Rattus norvegicus |
Striated muscle contraction |
https://identifiers.org/wikipathways/WP316_r117022 |
Rattus norvegicus |
TCA cycle |
https://identifiers.org/wikipathways/WP347_r124581 |
Rattus norvegicus |
TNF-alpha NF-kB signaling pathway |
https://identifiers.org/wikipathways/WP457_r117025 |
Rattus norvegicus |
Toll-like receptor signaling pathway |
https://identifiers.org/wikipathways/WP1309_r72183 |
Rattus norvegicus |
Translation factors |
https://identifiers.org/wikipathways/WP149_r117026 |
Rattus norvegicus |
Tryptophan metabolism |
https://identifiers.org/wikipathways/WP270_r104907 |
Rattus norvegicus |
Wnt signaling pathway and pluripotency |
https://identifiers.org/wikipathways/WP1288_r127644 |
Rattus norvegicus |
p53 pathway |
https://identifiers.org/wikipathways/WP655_r128741 |
Rattus norvegicus |
p53 signal pathway |
https://identifiers.org/wikipathways/WP656_r107003 |
Saccharomyces cerevisiae |
Aerobic glycerol catabolism |
https://identifiers.org/wikipathways/WP224_r117270 |
Saccharomyces cerevisiae |
Anaerobic respiration |
https://identifiers.org/wikipathways/WP575_r89136 |
Saccharomyces cerevisiae |
Arginine degradation |
https://identifiers.org/wikipathways/WP54_r89653 |
Saccharomyces cerevisiae |
Asparagine biosynthesis |
https://identifiers.org/wikipathways/WP67_r117278 |
Saccharomyces cerevisiae |
Carbon monoxide dehydrogenase pathway |
https://identifiers.org/wikipathways/WP280_r89704 |
Saccharomyces cerevisiae |
Cell cycle and cell division |
https://identifiers.org/wikipathways/WP414_r117274 |
Saccharomyces cerevisiae |
Colanic acid building blocks biosynthesis |
https://identifiers.org/wikipathways/WP121_r125511 |
Saccharomyces cerevisiae |
Cysteine biosynthesis from homoserine |
https://identifiers.org/wikipathways/WP256_r125521 |
Saccharomyces cerevisiae |
Cytoplasmic ribosomal proteins |
https://identifiers.org/wikipathways/WP210_r117045 |
Saccharomyces cerevisiae |
Cytoplasmic tRNA synthetases |
https://identifiers.org/wikipathways/WP219_r117282 |
Saccharomyces cerevisiae |
De novo NAD biosynthesis |
https://identifiers.org/wikipathways/WP541_r117291 |
Saccharomyces cerevisiae |
De novo biosynthesis of pyrimidine deoxyribonucleotides |
https://identifiers.org/wikipathways/WP36_r124941 |
Saccharomyces cerevisiae |
Deoxyribose phosphate metabolism |
https://identifiers.org/wikipathways/WP228_r109414 |
Saccharomyces cerevisiae |
Fatty acid biosynthesis, initial steps |
https://identifiers.org/wikipathways/WP137_r117288 |
Saccharomyces cerevisiae |
Fatty acid elongation, saturated |
https://identifiers.org/wikipathways/WP380_r117293 |
Saccharomyces cerevisiae |
Fatty acid elongation, unsaturated |
https://identifiers.org/wikipathways/WP16_r124936 |
Saccharomyces cerevisiae |
Fatty acid oxidation |
https://identifiers.org/wikipathways/WP91_r124911 |
Saccharomyces cerevisiae |
Glutamate biosynthesis |
https://identifiers.org/wikipathways/WP77_r89655 |
Saccharomyces cerevisiae |
Glutamate degradation I |
https://identifiers.org/wikipathways/WP556_r97054 |
Saccharomyces cerevisiae |
Glutamate degradation III |
https://identifiers.org/wikipathways/WP503_r97401 |
Saccharomyces cerevisiae |
Glutamate degradation VII |
https://identifiers.org/wikipathways/WP559_r102422 |
Saccharomyces cerevisiae |
Glutamate degradation VIII |
https://identifiers.org/wikipathways/WP99_r97070 |
Saccharomyces cerevisiae |
Glycine biosynthesis |
https://identifiers.org/wikipathways/WP261_r92999 |
Saccharomyces cerevisiae |
Glycine degradation |
https://identifiers.org/wikipathways/WP345_r117303 |
Saccharomyces cerevisiae |
Glycolysis |
https://identifiers.org/wikipathways/WP253_r107251 |
Saccharomyces cerevisiae |
High-osmolarity glycerol (HOG) pathway |
https://identifiers.org/wikipathways/WP2838_r127796 |
Saccharomyces cerevisiae |
Histidine, purine, and pyrimidine superpathway |
https://identifiers.org/wikipathways/WP416_r122754 |
Saccharomyces cerevisiae |
Isoleucine and valine biosynthesis |
https://identifiers.org/wikipathways/WP359_r117304 |
Saccharomyces cerevisiae |
Isoleucine, leucine, and valine biosynthesis |
https://identifiers.org/wikipathways/WP198_r117306 |
Saccharomyces cerevisiae |
Lipases biosynthesis |
https://identifiers.org/wikipathways/WP71_r70049 |
Saccharomyces cerevisiae |
Meiotic recombination genes |
https://identifiers.org/wikipathways/WP377_r125517 |
Saccharomyces cerevisiae |
Methionine degradation |
https://identifiers.org/wikipathways/WP46_r117317 |
Saccharomyces cerevisiae |
Mitochondrial tRNA synthetases |
https://identifiers.org/wikipathways/WP62_r117312 |
Saccharomyces cerevisiae |
NAD biosynthesis |
https://identifiers.org/wikipathways/WP84_r117316 |
Saccharomyces cerevisiae |
NAD salvage pathway |
https://identifiers.org/wikipathways/WP171_r117313 |
Saccharomyces cerevisiae |
Nucleotide metabolism |
https://identifiers.org/wikipathways/WP321_r117315 |
Saccharomyces cerevisiae |
Octane oxidation |
https://identifiers.org/wikipathways/WP552_r69954 |
Saccharomyces cerevisiae |
P-cymene degradation |
https://identifiers.org/wikipathways/WP181_r117318 |
Saccharomyces cerevisiae |
Pantothenate and coenzyme A biosynthesis |
https://identifiers.org/wikipathways/WP462_r126683 |
Saccharomyces cerevisiae |
Pentose phosphate pathway |
https://identifiers.org/wikipathways/WP369_r117320 |
Saccharomyces cerevisiae |
Pentose phosphate pathway 2 |
https://identifiers.org/wikipathways/WP670_r117321 |
Saccharomyces cerevisiae |
Phenylalanine, tyrosine, and tryptophan biosynthesis |
https://identifiers.org/wikipathways/WP27_r117323 |
Saccharomyces cerevisiae |
Phosphatidic acid and phospholipid biosynthesis |
https://identifiers.org/wikipathways/WP472_r117324 |
Saccharomyces cerevisiae |
Polyamine biosynthesis |
https://identifiers.org/wikipathways/WP290_r117328 |
Saccharomyces cerevisiae |
Principal pathways of carbon metabolism |
https://identifiers.org/wikipathways/WP112_r117329 |
Saccharomyces cerevisiae |
Proteasome degradation |
https://identifiers.org/wikipathways/WP158_r117064 |
Saccharomyces cerevisiae |
Protein modifications |
https://identifiers.org/wikipathways/WP346_r117330 |
Saccharomyces cerevisiae |
Purine fermentation |
https://identifiers.org/wikipathways/WP463_r117332 |
Saccharomyces cerevisiae |
Pyruvate dehydrogenase pathway |
https://identifiers.org/wikipathways/WP214_r125509 |
Saccharomyces cerevisiae |
Riboflavin, FMN, and FAD biosynthesis |
https://identifiers.org/wikipathways/WP381_r117333 |
Saccharomyces cerevisiae |
Ribose and deoxyribose phosphate metabolism |
https://identifiers.org/wikipathways/WP220_r117334 |
Saccharomyces cerevisiae |
Serine and glycine biosynthesis |
https://identifiers.org/wikipathways/WP218_r117337 |
Saccharomyces cerevisiae |
Serine biosynthesis |
https://identifiers.org/wikipathways/WP459_r117338 |
Saccharomyces cerevisiae |
Serine-isocitrate lyase pathway |
https://identifiers.org/wikipathways/WP390_r102418 |
Saccharomyces cerevisiae |
Sucrose biosynthesis |
https://identifiers.org/wikipathways/WP14_r125514 |
Saccharomyces cerevisiae |
Sulfate assimilation and copper detoxification |
https://identifiers.org/wikipathways/WP4173_r114094 |
Saccharomyces cerevisiae |
Sulfate assimilation pathway II |
https://identifiers.org/wikipathways/WP579_r89709 |
Saccharomyces cerevisiae |
Sulfur amino acid biosynthesis |
https://identifiers.org/wikipathways/WP7_r124904 |
Saccharomyces cerevisiae |
TCA cycle - detailed |
https://identifiers.org/wikipathways/WP296_r117347 |
Saccharomyces cerevisiae |
Threonine and methionine biosynthesis |
https://identifiers.org/wikipathways/WP423_r117348 |
Saccharomyces cerevisiae |
Toluene degradation |
https://identifiers.org/wikipathways/WP60_r89654 |
Saccharomyces cerevisiae |
Translation factors |
https://identifiers.org/wikipathways/WP32_r117350 |
Saccharomyces cerevisiae |
Trehalose degradation, low osmolarity |
https://identifiers.org/wikipathways/WP70_r119989 |
Saccharomyces cerevisiae |
UDP-N-acetylgalactosamine biosynthesis |
https://identifiers.org/wikipathways/WP159_r117359 |
Saccharomyces cerevisiae |
UDP-glucose conversion |
https://identifiers.org/wikipathways/WP109_r117358 |
Saccharomyces cerevisiae |
Upiquinone Q prenylation |
https://identifiers.org/wikipathways/WP287_r117360 |
Saccharomyces cerevisiae |
Xylulose-monophosphate cycle |
https://identifiers.org/wikipathways/WP361_r87431 |
Solanum lycopersicum |
ABA biosynthesis |
https://identifiers.org/wikipathways/WP2626_r120717 |
Solanum lycopersicum |
Gluconeogenesis |
https://identifiers.org/wikipathways/WP2630_r107270 |
Sus scrofa |
Amino acid conjugation of benzoic acid |
https://identifiers.org/wikipathways/WP1577_r125586 |
Sus scrofa |
Burn wound healing |
https://identifiers.org/wikipathways/WP5058_r128421 |
Zea mays |
Lycopene biosynthesis |
https://identifiers.org/wikipathways/WP2204_r123061 |